
维百奥生物特约代理Athens Research & Technology产品
Athens Research & Technology Inc.自1986年起始终专注于人类蛋白质纯化及相应多克隆抗血清开发。致力于提供高纯度、高活性的人类蛋白质产品,常规纯化范围涵盖丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白、血小板蛋白、转铁蛋白、免疫球蛋白等。二十五年来,全球科研机构持续采用我们的研究试剂,相关成果已发表于炎症、冠心病、自身免疫疾病、癌症、阿尔茨海默病等重要科学出版物。公司同时提供动物血清与组织来源的蛋白质分离服务。其产品被国际诊断及制药行业领导者广泛应用于体外诊断试剂盒、免疫检测试剂盒组分,以及干细胞培养等细胞培养基体系。

▌Athens Research & Technology产品线
| Coagulation Factors | Low Endotoxin Level Proteins | Transport/Other Proteins | Assay Kits |
| Enzymes & Inhibitors | Milk & Platelet Proteins | All Human Proteins | Recombinant |
| Immunoglobulins | Neutrophil Proteins | All Animal Proteins | Antibodies |
| Lipoproteins & Apolipoproteins | Transferrins & Apotransferrins |
▌Athens Research & Technology部分产品列表
| 品名 | 货号 | 规格 |
| Alpha 2 Antiplasmin | 16-16-012901 | 100 ug; 500 ug; 1 mg |
| Antithrombin III | 16-16-012020 | 100 ug; 1 mg |
| Kallikrein | 16-16-110112 | 50 ug |
| Kallikrein (lyophilized) | 16-16-110112-L | 50 ug |
| Kininogen, HMW | 16-16-110914-H | 100 ug |
| Plasmin, Frozen | 16-16-161213-F | 1 mg |
| Plasmin, Lyophilized | 16-16-161213-L | 500 ug; 1 mg |
| Plasminogen | 16-16-161200 | 1 mg |
| Platelet Factor 4 | 16-20-060306 | 100 ug |
| Thrombospondin | 16-20-201319 | 25 ug; 100 ug; 1 mg |
| Vitronectin | 16-16-220920 | 100 ug |
| Alpha 1 Antichymotrypsin | 16-16-012400 | 100 ug; 1 mg |
| Alpha 1 Antitrypsin | 16-16-011609 | 1 mg,10 mg; 5 mg,25 mg |
| Alpha 2 Antiplasmin | 16-16-012901 | 100 ug,1 mg; 500 ug |
| Alpha 2 Macroglobulin | 16-16-012013 | 1 mg,10 mg; 5 mg |
| Alpha 2 Macroglobulin, Fast Form | 16-16-012013-FF | 500 ug; 1 mg |
| Antithrombin III | 16-16-012020 | 100 ug; 1 mg |
| ApoCeruloplasmin | 16-16-A30518 | - |
| C1 Esterase Inhibitor | 16-16-031509 | 1 mg |
| Calpain-1 | 16-05-030112 | 100 ug; 500 ug |
| Catalase | 16-05-030000 | 500 ug; 1 mg |
| Catalase, Recombinant Microbial (Swissaustral USA) | 16-13-030000 | 20 mg; 100 mg |
| Cathepsin B | 16-12-030102 | 25 ug; 50 ug |
| Cathepsin D | 16-12-030104 | 25 ug,100 ug; 50 ug |
| Cathepsin G | 16-14-030107 | 50 ug; 100 ug |
| Cathepsin H | 16-12-030108 | 25 ug; 100 ug |
| Cathepsin L | 16-12-030112 | 25 ug; 100 ug |
| Ceruloplasmin | 16-16-030518 | 1 mg; 5 mg |
| Chymotrypsin | 16-19-030820 | 100 ug; 1 mg |
| Defensins, Alpha, Mixed | 16-14-081416 | 100 ug; 1 mg |
| Dipeptidyl Peptidase IV | 16-23-041606 | 10 mU |
| Elastase | 16-14-051200 | 50 ug,1 mg; 100 ug |
| Glutamate Dehydrogenase, Recombinant Microbial (Swissaustral USA) | 16-13-070408 | 1,000 EU,5,000 EU; 2,000 EU,10,000 EU |
| Haptoglobin, Phenotype 2-2 | 16-16-080116-2/2 | 1 mg |
| Inter Alpha Inhibitor Proteins (IaIp) | 16-16-090109 | 25 ug,1 mg; 100 ug |
| Kallikrein | 16-16-110112 | 50 ug |
| Kallikrein (lyophilized) | 16-16-110112-L | 50 ug |
| Kallikrein, Cynomolgus Monkey | 16-16-110112-CM | 50 ug |
| Kininogen, HMW | 16-16-110914-H | 100 ug |
| Kininogen, LMW | 16-16-110914-L | 100 ug; 1 mg |
| Laccase (LAC), Recombinant Microbial (Swissaustral USA) | 16-13-120100 | 1,500 KU,5,000 KU; 3,000 KU,10,000 KU |
| Lysozyme | 16-14-122519 | 100 ug; 1 mg |
| Myeloperoxidase | 16-14-130000 | 100 ug,10 mg; 1 mg |
| Plasmin, Frozen | 16-16-161213-F | 1 mg |
| Plasmin, Lyophilized | 16-16-161213-L | 500 ug; 1 mg |
| Plasminogen | 16-16-161200 | 1 mg |
| Proteinase 3 (PR3) | 16-14-161820 | 25 ug,1 mg; 100 ug |
| rPR3, HEK293 Cells, Glycosylation Mutant | 16-18-161813 | - |
| rPR3, HEK293 Cells, Wild Type | 16-18-161820 | - |
| Superoxide Dismutase | 16-05-191504 | 100 ug |
| Trypsin | 16-19-032000 | 100 ug; 1 mg |